郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Pharmacological and physiological characterization of d[Leu4, Lys8]vasopressin, the first V1b-selective agonist for rat vasopressin/oxytocin receptors.

期刊：Endocrinology发表年份：2007作者：Ana Pena; Brigitte Murat; Miguel Trueba; Maria A Ventura; Gyslaine Bertrand; Ling Ling Cheng; Stoytcho Stoev; Hazel H Szeto; Nga Wo; Gabrielle Brossard; Claudine Serradeil-Le Gal; Maurice Manning; Gilles Guillon
阅读更多 →

药效评价Involvement of the sigma1 (sigma1) receptor in the anti-amnesic, but not antidepressant-like, effects of the aminotetrahydrofuran derivative ANAVEX1-41.

期刊：British journal of pharmacology发表年份：2007作者：J Espallergues; P Lapalud; A Christopoulos; V A Avlani; P M Sexton; A Vamvakides; T Maurice
阅读更多 →

药效评价Fluorescence resonance energy transfer analysis of secretin docking to its receptor: mapping distances between residues distributed throughout the ligand pharmacophore and distinct receptor residues.

期刊：The Journal of biological chemistry发表年份：2007作者：Kaleeckal G Harikumar; Polo C-H Lam; Maoqing Dong; Patrick M Sexton; Ruben Abagyan; Laurence J Miller
阅读更多 →

药效评价Growth Hormone (GH) receptor C.1319 G>T polymorphism, but not exon 3 retention or deletion is associated with better first-year growth response to GH therapy in patients with GH deficiency.

期刊：Pediatric research发表年份：2007作者：Lei Wan; Wei-Cheng Chen; Yuhsin Tsai; Yu-Tsun Kao; Yao-Yuan Hsieh; Cheng-Chun Lee; Chang-Hai Tsai; Chih-Ping Chen; Fuu Jen Tsai
阅读更多 →